Director Procurement - API and Excipients Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performan...
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the imm...
At GSK we are looking for a highly capable senior technical builder who can design and govern the data-flows that GSK’s Research & Development (R&D) division runs on. If you believe data should move on its own and still arrive trusted, then...
Quality Validation and CSV Senior Specialist (1x Perm, 1x FTC/Secondment) Closing Date: 9th November 2026 (COB) Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and...
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the imm...
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our u...
At GSK, we want to supercharge our data capability to better understand our patients and accelerate our ability to discover vaccines and medicines. The Onyx Research Data Platform organization represents a major investment by GSK R&D and Di...
Tablet Packaging Compliance & Project Support Closing Date: 2nd November 2026 (COB) Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our n...
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the imm...
Business Introduction: We are a specialist pharmaceutical company 100% dedicated to developing medicines to treat and prevent HIV. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, our ambition is to...